Approaching the facts between genetic mutation and clinical practice of hypertrophic cardiomyopathy-Reference-Cited by-同舟云学术

Approaching the facts between genetic mutation and clinical practice of hypertrophic cardiomyopathy

Published:2016-09 Issue:37 Volume:95 Page:e4815
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Wang Xiaoqin,Zhou Kaiyu,Hua Yimin,Li Yifei

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference12 articles.

1. Hypertrophic cardiomyopathy: from gene defect to clinical disease;Chung;Cell Res,2003

2. Understanding cardiomyopathy phenotypes based on the functional impact of mutations in the myosin motor;Moore;Circ Res,2012

3. Right ventricular hypertrophy is associated with cardiovascular events in hypertrophic cardiomyopathy: evidence from study with magnetic resonance imaging;Nagata;Can J Cardiol,2015

4. Cyclosporine attenuates cardiomyocyte hypertrophy induced by raf1 mutants in Noonan and Leopard syndromes;Dhandapany;J Mol Cell Cardiol,2011

5. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines;Gersh;Circulation,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining the variant-phenotype correlation in patients affected by Noonan syndrome with the RAF1:c.770C>T p.(Ser257Leu) variant;European Journal of Human Genetics;2024-06-01

2. MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations;BMC Cardiovascular Disorders;2022-06-18

3. Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the Literature;Genetics in Medicine;2019-01

4. Progress of Genetics in Inherited Cardiomyopathies-Induced Heart Failure;Translational Bioinformatics;2018

5. Exogenous cathepsin V protein protects human cardiomyocytes HCM from angiotensin Ⅱ-Induced hypertrophy;The International Journal of Biochemistry & Cell Biology;2017-08